The RSNA Board of Directors has determined these courses to be of particular importance, and increased audience interest is expected. All courses are presented from 4:30 to 6 p.m. today.
Imaging Cognition 2018: Addiction
Sessions cover the increasingly important role of radiology in understanding the science of imaging as it relates to studying addiction. After an introduction on "Addiction in America 2018," sessions will focus in PET, fMRI and MR spectroscopy in addiction, concluding with a panel discussion.
Quantitative Imaging Applications in Screening, Treatment Selection, and Treatment Assessment – The Need for Standardization in the Era of Personalized Medicine
Presenters will discuss opportunities and advantages of quantitative imaging biomarkers in clinical research. The session will highlight initiatives of the RSNA Quantitative Imaging Biomarkers Alliance (QIBA) and other quantitative imaging efforts seeking to translate quantitative imaging measures from academic centers of excellence to clinical trial applications to patient care in the era of precision medicine.
Demystifying Machine Learning and Artificial Intelligence for the Radiologist
Presenters will address the current concerns of radiologists, present cutting-edge research and provide insight into the impact of machine learning and artificial intelligence on the future of radiology. The session will conclude with a Q&A with presenters.
High–Value MRI: Updates from the February 2018 ISMRM–RSNA Co–provided Workshop
The session offers a review of the RSNA/International Society for Magnetic Resonance in Medicine (ISMRM) workshop on High-Value MRI. Sessions will focus on clinical advances that are achievable, meaningful and impactful in moving the value of MRI forward.
Academy for Radiology and Biomedical Imaging Research Imaging Shark Tank Session
A panel of experts in IP, venture capital and industry will discuss how investigators can best present translational research and technology ideas to the industry and alternate non-governmental funding sources.
Integrated Diagnostics-Combining Genomics, Pathology and Radiology: The Future Now
Presenters will discuss the concept of integrated diagnosis, which combines radiology, pathology and genomics into an innovative diagnostic tool.
High Impact Clinical Trials
Late-breaking clinical trials selected for their significant contributions to radiology research will be discussed:
- Efficacy and Safety of Transdermal, Sublingual, and Oral Nitroglycerin Administration for Coronary CT Angiography: Results of a Prospective Randomized Trial
- Optoacoustic Imaging is Helpful in Predicting Breast Cancer Molecular Subtypes
- Safety and Tolerability of High-Specific-Activity I-131 MIBG (AZEDRA®) in Patients with Iobenguane Scan Positive Cancers: A Pooled Analysis Across AZEDRA Clinical Studies